Skip to main content
Signal8

BOBULSKY SUSAN

SEC insider (Form 3/4/5 filer). CIK 0001820885. Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp (ADPT). 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in SEATTLE, WA.

Companies BOBULSKY SUSAN has filed insider reports for

  • Adaptive Biotechnologies Corp (ADPT): Officer, Chief Commercial Officer, MRD
BOBULSKY SUSAN profile photo

BOBULSKY SUSAN

CIK: 0001820885

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (73.3%)

Position reduction

Option Exercises (M)1 (6.7%)

Derivative conversions

Awards (A)3 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Adaptive Biotechnologies Corp logo
ADPT

Adaptive Biotechnologies Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Oct 6, 2026
    Sale
    Direct
    6.4K shares at avg. $30.00$193K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Sep 15, 2026
    Sale
    Direct
    1.2K shares at avg. $27.00$32K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Aug 10, 2026
    Sale
    Direct
    3K shares at avg. $25.00$75K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jul 30, 2026
    Sale
    Direct
    1.3K shares at avg. $24.00$31K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jul 16, 2026
    Sale
    Direct
    5K shares at avg. $23.00$115K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jul 1, 2026
    Sale
    Direct
    487 shares at avg. $22.00$11K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 25, 2026
    Sale
    Direct
    5K shares at avg. $20.50$103K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 11, 2026
    Sale
    Direct
    5K shares at avg. $19.00$95K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 4, 2026
    Sale
    Direct
    11K shares at avg. $18.00$198K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Mar 11, 2026
    Sale
    Direct
    41.3K shares at avg. $13.17$544K

1-10 of 15